Advancing American Freedom applauds FDA Director Makary for pledging to review the safety and efficacy of mifepristone. For too long, women’s health has been sacrificed for vested interests and political gains.
American women deserve an honest reassessment of mifepristone and the REMS essential to protecting women that have been increasingly stripped by Democratic Administrations, especially when the Ethics and Public Policy Center’s study of insurance claims suggests adverse effects 22 times higher than previously acknowledged by the FDA.